Pipeline & Medicines Explore the Science of Possibility View Vertex Research Giving BackLearn more about our STEM Program, Volunteer Efforts, Grants and Funding./giving-back Recent UpdatesFDA Approves SYMDEKOExpanded EU Approval for ORKAMBIKALYDECO Approved for Additional Mutations The Stories Behind Vertex: Science Vertex Celebrates the 50th Science and Medicine Seminar Giving Back Vertex Scholarship Gives Students the Opportunity to Make a Difference in Health Care and the Environment Science Vertex Initiates Second Phase 3 VX-659 Triple Combination Study in Certain People with Cystic Fibrosis × We Are Vertex Day of Service Science Paul Negulescu Awarded the Warren Alpert Foundation Prize for Contributions to CF Science We Are Vertex Vertex’s Michael Parini Is Moved to Make a Difference Giving Back $1 Million In: The Power of a Double Donation All in for CF 11-Year-Old with Cystic Fibrosis Joins Team Sports for the First Time Through the Vertex Team IMPACT CF Project We Are Vertex Voices From Clinical Development: How Compounds Discovered in the Lab Translate to a Clinical Setting × All in for CF Amanda and Peter Krug Share Their Perspective on What It Takes To Care for Harry, Their 10-Year-Old Son Who Is Living with Cystic Fibrosis Explore More Stories @vertexpharma
Giving Back Vertex Scholarship Gives Students the Opportunity to Make a Difference in Health Care and the Environment
Science Vertex Initiates Second Phase 3 VX-659 Triple Combination Study in Certain People with Cystic Fibrosis
All in for CF 11-Year-Old with Cystic Fibrosis Joins Team Sports for the First Time Through the Vertex Team IMPACT CF Project
We Are Vertex Voices From Clinical Development: How Compounds Discovered in the Lab Translate to a Clinical Setting
× All in for CF Amanda and Peter Krug Share Their Perspective on What It Takes To Care for Harry, Their 10-Year-Old Son Who Is Living with Cystic Fibrosis
